Why Safety Matters - Lilly's Commitment to Patient Safety
Beginning with the discovery of a potential new medicine, and for as long as it is available to patients, our goal is to ensure that the benefits and risks of a medication are continuously monitored and well-understood by regulators, healthcare providers and patients.
Lilly maintains a pharmacovigilance system, collecting data throughout the lifecycle of each product. This system is designed to continually maintain and evaluate the product's benefit/risk profile. When important safety issues arise, Lilly communicates them to doctors, patients and regulatory agencies.
Lilly's Global Patient Safety (GPS) organization, consisting of more than 300 physicians, pharmacists, nurses and other healthcare providers, is dedicated to the collection, monitoring, evaluation and reporting of safety information.